Micro-x Ltd. · ASX:MX1
Micro-x — 14th Bioshares Biotechnology Summit 2018
17 slides from Micro-x's conference presentation, Jul 30, 2018
Slide 1: ASX Announcement: Presentation at 14th Bioshares Biotech Summit
Micro-X Limited, 1284 South Road, Tonsley, South Australia, 5042 ABN: 21 153 273 735 For personal use only Monday 30th July 2018 ASX Announcement – MICRO-X LIMITED (ASX: MX1) PRESENTATION AT 14TH BIOSHARES BIOTECH SUMMIT Micro-X Limited’s (‘Micro-X’) Managing Director, Peter Rowland, was invited to
Slide 2: Micro-X: A New Era in X-Ray Imaging
For personal use only Ltd ACN 153 273 735 2018 Bioshares Biotechnology Summit, Queenstown NZ The Investment Proposition: The End Justifies the Means Micro-X: A New Era in X-Ray Imaging Peter Rowland, Managing Director Saturday 28th July 2018 © Micro-X Ltd 2018 Commercial-in-Confidence
Slide 3: Medical Devices: Does the End Justify the Means?
Bioshares Session Theme For personal use only Medical Devices: Does the End Justify the Means? “It is a costly, capital intensive process to develop cutting-edge medical devices and diagnostics and then to launch and compete with products in global markets in a bid to create a viable, high growth bu
Slide 4: The MX1 Core Business Model
The MX1 Core Business Model: Developing & manufacturing innovative, ultra-lightweight, x-ray imaging For personal use only products for global medical and security markets. • Core technology is Carbon Nano-Tube (CNT) emitters • Exclusively licenced from technology partner XinRay Systems • Enables sm
Slide 5: Micro-X's Five Biggest Challenges getting here
Micro-X’s Five Biggest Challenges getting here For personal use only Creating the CNT Technology Platform • Unexpected core technology issues had to be solved • Achieving engineering & production discipline in scientific/academic organisations • New vacuum physics learnings of tube operation • Low s
Slide 6: The Long-Term Strategy Hasn't Changed
The Long-Term Strategy Hasn’t Changed For personal use only A journey of 1,000 miles starts with a single step • Prove the CNT technology platform with the Carestream DRX Revolution Nano • Prove the MX1 team can deliver world-class innovation, design and manufacture • Become established in both Medi
Slide 7: Challenges: Profiting from staying in control of CNT x-ray
Future Challenges For personal use only Fully Understanding the Global significance of this technology leap: Profiting from staying in control of CNT x-ray • Micro-X now recognised globally for creating the first cold-cathode X-Ray product • Multiple attractive product applications with no competito
Slide 8: Grand Alliance
Grand Alliance For personal use only Partnering to Accelerate Global Commercialisation • Collaboration discussions have progressed well with a number of global & technology radiology companies • MX1 is looking in the Alliance to achieve: • A shared vision for technology and applications • Investment
Slide 9: First Product – Now On Sale
First Product – Now On Sale For personal use only Carestream DRX Revolution Nano • Carestream sales and marketing now taking orders • MX1 production deliveries against first order • A short hiatus currently while some issues with air freight damage being resolved • Expecting a strong Q4CY18 • Addres
Slide 10: Opportunity in Development: Rover Mobile X-Ray
Future Product Opportunity in Development For personal use only Rover – Mobile X-Ray for Deployed Military Medical Facilities • X-Ray tube re-designed for the more demanding, higher-energy exams used in trauma medicine • Operated up to 10kW (100kV, 100mAs) • Imaging tests for Australian Defence Forc
Slide 11: Mobile Backscatter Imager for Counter-IED Assessment
Future Product Opportunity in Development For personal use only Mobile Backscatter Imager (MBI) for Counter-IED Assessment • Today Explosive Ordnance Disposal technicians exposed to high risk acquiring x-ray image to assess and render-safe IEDs • MX1 has demonstrated stand-off backscatter imaging to
Slide 12: Opportunity: Brain Perfusion CT Imaging
Future Product Opportunity: • Stroke dichotomy: Thrombotic or Brain Perfusion CT Imaging Haemorrhagic? CT diagnosis must For personal use only precede treatment • Time to commencement of treatment biggest factor in recovery and on-going patient care costs. • Stroke Ambulance is single-purpose due to
Slide 13: Opportunity: 3D Breast Imaging for Screening
Future Product Opportunity: 3D Breast Imaging for Screening For personal use only • 2D projection x-ray imaging being replaced by 3D CT to improve diagnosis • Pain from 30kg breast compression forces in current technology reduces patient participation in screening • CNT technology product offers: •
Slide 14: Opportunity: Bedside Cone Beam CT Imaging
Future Product Opportunity: For personal use only Bedside Cone Beam CT Imaging • Risks in moving ICU Patients for a conventional CT scan • Mobile Tomosynthesis Applications include: • Coronary Artery CT, Pneumothorax, Pulmonary Tuberculosis, Nontuberculosis Mycobacterial Disease, Cystic Fibrosis • C
Slide 15: Opportunity: Airport Checkpoint X-Ray Security
Future Product Opportunity: For personal use only Airport Checkpoint X-Ray Security • Contract from UK Government Future Airport Security Solutions • “Finding Explosives in Electronics” leads to next- generation checkpoint x-ray • Future Airport Checkpoint X-Ray concept uses same imaging module tech
Slide 16: Valuing MX1
Valuing MX1 For personal use only Does the End Justify the Means? - Valuing the whole Product Roadmap • MX1’s investment to date in its capability and its platform technology will support multiple future valuable products • Commercialising products quickly is important to derive most value • Buildin
Slide 17: Questions…?
For personal use only Questions…? © Micro-X Ltd 2018 Commercial-in-Confidence